Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1126 AL 1140

The Emerging Role of Neuropeptides in Parkinson's Disease

Zheng Y, Zhang L, Xie J, Shi L.

Front Aging Neurosci. 2021 Mar 8;13:646726. doi: 10.3389/fnagi.2021.646726. eCollection 2021.

Mitochondrial Behavior in Axon Degeneration and Regeneration

Wang B, Huang M, Shang D, Yan X, Zhao B, Zhang X.

Front Aging Neurosci. 2021 Mar 8;13:650038. doi: 10.3389/fnagi.2021.650038. eCollection 2021.

A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene

Vinagre-Aragón A, Campo-Caballero D, Mondragón-Rezola E, Pardina-Vilella L, Hernandez Eguiazu H, Gorostidi A, Croitoru I, Bergareche A, Ruiz-Martinez J.

Front Neurol. 2021 Mar 2;12:635396. doi: 10.3389/fneur.2021.635396. eCollection 2021.

Case Report: Ziprasidone induced neuroleptic malignant syndrome

Sedhai YR, Atreya A, Phuyal P, Basnyat S, Pokhrel S.

F1000Res. 2021 Feb 17;10:124. doi: 10.12688/f1000research.51094.1. eCollection 2021.

Association of Parkinson's Disease With Microbes and Microbiological Therapy

Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, Li XF, Gao BL.

Front Cell Infect Microbiol. 2021 Mar 8;11:619354. doi: 10.3389/fcimb.2021.619354. eCollection 2021.

Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics

Banerjee A, Pradhan LK, Sahoo PK, Jena KK, Chauhan NR, Chauhan S, Das SK.

Arch Microbiol. 2021 Aug;203(6):2895-2910. doi: 10.1007/s00203-021-02276-9. Epub 2021 Mar 24.

A Phase 2 Proof-of-Concept, Randomized, Placebo-Controlled Trial of CX-8998 in Essential Tremor

Papapetropoulos S, Lee MS, Versavel S, Newbold E, Jinnah HA, Pahwa R, Lyons KE, Elble R, Ondo W, Zesiewicz T, Hedera P, Handforth A, Elder J, Versavel M.

Mov Disord. 2021 Aug;36(8):1944-1949. doi: 10.1002/mds.28584. Epub 2021 Mar 25.

Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks

El-Gamal M, Salama M, Collins-Praino LE, Baetu I, Fathalla AM, Soliman AM, Mohamed W, Moustafa AA.

Neurotox Res. 2021 Jun;39(3):897-923. doi: 10.1007/s12640-021-00356-8. Epub 2021 Mar 25.

Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson's disease and related disorders

Jimenez-Shahed J.

Expert Rev Med Devices. 2021 Apr;18(4):319-332. doi: 10.1080/17434440.2021.1909471. Epub 2021 Apr 5.

Impact of subthreshold depression on health-related quality of life in patients with Parkinson's disease based on cognitive status

Schönenberg A, Zipprich HM, Teschner U, Grosskreutz J, Witte OW, Prell T.

Health Qual Life Outcomes. 2021 Mar 25;19(1):107. doi: 10.1186/s12955-021-01753-5.

New Drug Update 2020

Hussar DA, Finn LA.

Sr Care Pharm. 2021 Apr 1;36(4):176-186. doi: 10.4140/TCP.n.2021.176.

Anaesthetic challenges in a patient with Wolff-Parkinson-White (WPW) syndrome for orchidectomy

Yeap TB, Teah MK, Thevarajah S, Azerai S.

BMJ Case Rep. 2021 Mar 25;14(3):e241176. doi: 10.1136/bcr-2020-241176.

Editorial: Vitamin D in Neurological Diseases: From Pathophysiology to Therapy

Smolders J, Hiller A, Camu W.

Front Neurol. 2021 Mar 9;12:614900. doi: 10.3389/fneur.2021.614900. eCollection 2021.

Environmental and occupational exposure to metals (manganese, mercury, iron) and Parkinson's disease in low and middle-income countries: a narrative review

Gonzalez-Alvarez MA, Hernandez-Bonilla D, Plascencia-Alvarez NI, Riojas-Rodriguez H, Rosselli D.

Rev Environ Health. 2021 Mar 26;37(1):1-11. doi: 10.1515/reveh-2020-0140. Print 2022 Mar 28.

Utility of objective gait measures in levodopa-unresponsive freezing in Parkinson's

Virmani T, Glover A, Pillai L, Lotia M, Dhall R.

Clin Case Rep. 2021 Jan 13;9(3):1072-1077. doi: 10.1002/ccr3.3640. eCollection 2021 Mar.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias